Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03856086
Other study ID # 18-539
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date February 25, 2019
Est. completion date February 2025

Study information

Verified date March 2024
Source Memorial Sloan Kettering Cancer Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will help the researchers find out whether the S+C approach is better, the same as, or worse than EUC.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 150
Est. completion date February 2025
Est. primary completion date February 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Self-identified caregiver to a patient receiving surgery at JRSC OR self-identified caregiver to a patient at various inpatient surgical floors (i.e., M4, M7, M8) at the Main Hospital OR self-identified caregiver to a patient at the BMT clinic. - English fluency: Self-report by subject identifying English as the preferred language for healthcare, and self-reported degree of fluency as speaking English "Very well." - 18 years old or older as per self report - Agree to fulfill responsibilities as an IC during the perioperative phases as per self report Exclusion Criteria: - Cognitive difficulties that preclude participation in the intervention or accurate assessment in the judgment of the PI - Medical illness that is of sufficient severity to preclude further participation in the study. - Presenting to JRSC as the IC for a patient undergoing a prophylactic procedure

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Baseline questionnaire
Baseline questionnaire on the day of the patient's surgery.
NCCN Problem List
NCCN Distress Thermometer
FACT-GP
Greater overall quality of life
HADS
Lower anxiety and depression
CSS-CG
web-based CSS-CG

Locations

Country Name City State
United States Memorial Sloan Kettering Cancer Center New York New York

Sponsors (2)

Lead Sponsor Collaborator
Memorial Sloan Kettering Cancer Center University of Virginia

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of Informal caregivers with unmet needs comparing the 3-month change scores on the NCCN problem list from baseline 1 year
See also
  Status Clinical Trial Phase
Recruiting NCT04478851 - EXCEL: Exercise for Cancer to Enhance Living Well N/A